Anthony Todd M. 4

What Happened Anthony M. Todd, Vice President of Organizational Development at Cumberland Pharmaceuticals (CPIX), was granted 3,000 shares as an award on March 18, 2026. The award is reported as a derivative acquisition at an attributed price of $2.80 per share, for a notional value of $8,400. This is an equity award (Form 4 code A), which is an acquisition rather than a sale and commonly reflects compensation rather than an open-market purchase.

Key Details

• Transaction date: 2026-03-18; Report filed: 2026-03-20 (filed within the typical two-business-day Form 4 window).
• Award: 3,000 shares; attributed price $2.80; total value shown $8,400.
• Security type: Derivative award/grant (Form 4 code A).
• Shares owned after the transaction: Not specified in the provided filing.
• No tax withholding, cashless exercise, or 10b5-1 plan noted in the provided information.

Context This was an equity award granted to an executive as part of compensation; such awards are routine and do not by themselves signal a buy or sell decision in the open market. The reported value is modest (~$8.4k), and because it’s a derivative award, vesting or other conditions may apply before the shares become freely tradable.